Search Results - "Schmerböck, B"

Drop of FGF19 levels in patients with HCC development following DAA therapy for chronic hepatitis C by Stadlbauer, V, Schmerböck, B, Leber, B, Kipperer, M, Stiegler, P, Posch, A, Streit, A, Spindelböck, W, Fickert, P, Stauber, R

Get full text

Direct acting antivirals improve neutrophil phagocytic capacity in chronic hepatitis C by Leber, B, Horvath, A, Schmerböck, B, Tawdrous, M, Streit, A, Posch, A, Fickert, P, Spindelböck, W, Stiegler, P, Stauber, R.E, Stadlbauer, V

Get full text

SAT-209 - Drop of FGF19 levels in patients with HCC development following DAA therapy for chronic hepatitis C by Stadlbauer, V., Schmerböck, B., Leber, B., Kipperer, M., Stiegler, P., Posch, A., Streit, A., Spindelböck, W., Fickert, P., Stauber, R.

Get full text

THU-235 - Direct acting antivirals improve neutrophil phagocytic capacity in chronic hepatitis C by Leber, B., Horvath, A., Schmerböck, B., Tawdrous, M., Streit, A., Posch, A., Fickert, P., Spindelböck, W., Stiegler, P., Stauber, R.E., Stadlbauer, V.

Get full text